ConductScience.org, home

Trial · NCT00651261

Adverse events1,458

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherBlood disorderBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Midostaurin535511
otherBlood disorderBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Placebo43546
otherDisseminated intravascular coagulationBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Midostaurin23552
otherDisseminated intravascular coagulationBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Placebo13541
otherFebrile neutropeniaBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Midostaurin246355422
otherFebrile neutropeniaBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Placebo238354394
otherHemoglobin decreasedBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Midostaurin3123551,059
otherHemoglobin decreasedBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Placebo311354940
otherLymph node painBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Midostaurin23552
otherLymph node painBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Placebo03540
otherLymphatic disorderBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Midostaurin1035513
otherLymphatic disorderBlood and lymphatic system disordersInduction and Consolidation Chemotherapy Plus Placebo935411
otherArrhythmiaCardiac disordersInduction and Consolidation Chemotherapy Plus Midostaurin13551
otherArrhythmiaCardiac disordersInduction and Consolidation Chemotherapy Plus Placebo43544
otherAtrial fibrillationCardiac disordersInduction and Consolidation Chemotherapy Plus Midostaurin33553
otherAtrial fibrillationCardiac disordersInduction and Consolidation Chemotherapy Plus Placebo03540
otherAtrial flutterCardiac disordersInduction and Consolidation Chemotherapy Plus Midostaurin03550
otherAtrial flutterCardiac disordersInduction and Consolidation Chemotherapy Plus Placebo13541
otherAtrial tachycardiaCardiac disordersInduction and Consolidation Chemotherapy Plus Midostaurin13553
otherAtrial tachycardiaCardiac disordersInduction and Consolidation Chemotherapy Plus Placebo13541

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00651261/events